Results 131 to 140 of about 457,701 (285)
Recent advances in diagnostics have accelerated the development of miniaturized wearable technologies for the continuous monitoring of diseases. This paradigm is shifting healthcare away from invasive, centralized blood tests toward decentralized monitoring, using alternative body biofluids.
Lanka Tata Rao +2 more
wiley +1 more source
Human medicines European public assessment report (EPAR): Xeristar, duloxetine, Anxiety Disorders,Depressive Disorder, Major,Diabetic Neuropathies, Date of authorisation: 17/12/2004, Revision: 28, Status: Authorised [PDF]
Kernel Networks Inc.
openalex +1 more source
Advances in Bioprinting to Model Immune‐Mediated Skin Diseases
This review explores how 3D bioprinting drives innovation in developing in vitro skin models that mimic immune‐mediated diseases. It highlights current technologies, key applications in studying skin pathologies, and emerging challenges. The review points toward future opportunities for improving disease modeling and advancing therapeutic and cosmetic ...
Andrea Ulloa‐Fernández +4 more
wiley +1 more source
Boron‐Doped Nano‐Crystalline Coated Carbon Fibers for Phasic Dopamine Sensing
This uniform coating presents a mix of graphitic and diamond‐like carbon to create a mechanically and electrically robust alternative for the electrochemical detection of dopamine. The electrodes in this work possess the equivalent sensitivity to the state‐of‐the‐art FSCV dopamine detecting electrodes, whilst demonstrating an ability to withstand ...
Simon J. Higham +19 more
wiley +1 more source
MicroRNAs as Regulators of Neuroinflammation in Major Depressive Disorder. [PDF]
Li Q +7 more
europepmc +1 more source

